We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

TLK2 Enzyme: Potential Drug Target for Breast Cancer & Brain Condition

News   Jul 02, 2018 | Original story from the University of Copenhagen

 
TLK2 Enzyme: Potential Drug Target for Breast Cancer & Brain Condition

Credit: Pixabay

 
 
 

RELATED ARTICLES

Neurons Can Count

News

Researchers demonstrate that some brain cells fire mainly for quantities of three, others for quantities of four and others for other quantities.

READ MORE

Unprecedented View of Gene Therapy Virus

News

Using cryo-electron microscopy, scientists have obtained an unprecedented view of a gene-delivery virus, paving the way for further development of improved gene therapies.

READ MORE

Ovarian Cancer Biomarker Can Predict Patient Therapy Response

News

Researchers have identified an independent prognostic factor - cancer/testis antigen 45 (CT45) - and have begun to elucidate it's actions. CT45 is associated with extended disease-free survival for women with advanced ovarian cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cancer Research Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE